Cenomed BioSciences

Cenomed BioSciences LLC develops drug therapies for the treatment of neurological disorders. Its solutions are used to treat schizophrenia, mild cognitive impairment, memory/attention deficits, attention deficit hyperactivity disorder, as well as pain and chemical defense. The company was founded in 2007 and is headquartered in Irvine, California. Cenomed BioSciences LLC is a subsidiary of app Pharmaceuticals, Inc.